Orgenesis Inc. · OTC:ORGS

Orgenesis Inc. financial statements

Orgenesis Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2018FY2017FY2016
Revenue1.03M530.0K36.0M35.5M7.65M33.3M18.7M18.7M10.1M6.40M
Cost of revenue9.51M6.25M20.4M28.2M31.1M18.1M10.7M10.7M6.81M7.66M
Gross profit-8.47M-5.72M15.6M7.34M-23.4M15.1M7.96M7.96M3.28M-1.26M
Research and development3.84M11.1M6.01M36.6M84.0M12.5M6.46M6.46M2.48M2.16M
Selling, general and administrative12.9M34.6M16.2M15.4M19.4M25.3M16.6M16.6M10.7M6.45M
Operating income-26.1M-53.6M-7.54M-16.8M-95.8M-24.6M-14.7M-14.7M-11.2M11.3M
Depreciation and amortization2.09M1.56M1.98M1.86M1.44M3.81M2.62M2.62M2.60M2.92M
EBITDA-24.0M-52.1M-5.56M-14.9M-94.3M-20.8M-12.0M-12.0M-8.63M14.2M
Interest expense3.74M2.17M1.82M369.0K1.09M461.0K2.75M2.75M1.23M689.0K
Income before tax-48.9M-64.4M-12.0M-18.0M-96.7M-25.5M-17.8M-17.8M-13.7M-10.7M
Income tax473.0K209.0K108.0K-1.61M563.0K1.34M1.34M-1.31M-1.55M
Net income-48.2M-55.4M-14.9M-18.1M-95.8M-26.0M-18.3M-18.3M-12.4M-9.19M
Earnings per share, basic-9.31-1.91-0.59-0.74-4.49-1.64-1.37-1.37-1.27-1.08

Balance sheet

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2018FY2017FY2016
Cash and equivalents78.0K837.0K5.31M5.47M44.9M11.4M16.1M16.1M3.52M891.0K
Short-term investments152.0K
Receivables40.0K2.56M39.8M19.7M3.25M2.04M11.2M11.2M2.21M2.13M
Inventory034.0K120.0K118.0K185.0K2.04M1.74M1.74M725.0K400.0K
Current assets761.0K4.08M46.3M25.8M50.1M26.0M30.3M30.3M7.29M4.21M
Property, plant and equipment5.11M4.27M3.03M12.5M11.9M5.10M4.57M
Goodwill01.21M8.19M8.40M8.74M14.9M15.2M15.2M10.7M9.58M
Total assets1.35M14.6M90.9M59.8M77.7M92.5M75.4M75.4M39.9M33.5M
Accounts payable10.4M6.58M4.43M5.24M8.65M5.55M3.80M3.80M3.91M4.55M
Current liabilities26.9M16.4M15.9M15.4M16.3M31.6M17.1M17.1M16.9M14.6M
Long-term debt8.47M19.0M13.3M4.85M7.26M13.4M2.85M2.70M4.53M4.35M
Total debt22.6M20.3M11.8M12.9M24.8M3.73M3.73M7.69M9.84M
Total liabilities38.9M35.5M31.7M21.2M25.0M86.4M46.8M46.8M25.7M22.9M
Shareholders' equity-37.5M-21.0M27.6M38.5M52.6M5.48M28.4M28.6M14.1M10.6M
Shares outstanding5.17M29.0M25.1M24.3M21.3M15.9M13.4M13.4M9.71M8.52M

Cash flow

LineFY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2018FY2017FY2016
Cash from operations-17.1M-14.8M-24.9M-26.9M-78.0M-13.2M-15.7M-15.7M-3.83M-3.78M
Capital spending-263.0K-2.10M-12.4M-7.87M-1.52M-12.1M-5.56M-5.56M-975.0K-1.43M
Free cash flow-17.3M-16.9M-37.3M-34.7M-79.6M-25.3M-21.2M-21.2M-4.81M-5.21M
Cash from investing-3.71M-14.1M-12.4M105.6M-13.8M-6.27M-6.27M-3.40M-1.54M
Cash from financing16.0M13.6M39.6M-106.0K5.88M24.1M35.1M35.1M8.37M2.12M
Dividends paid-106.0K
Share buybacks-107.0K-1.02M-250.0K13.2M17.4M5.30M1.49M
Change in cash-752.0K-4.89M395.0K-39.6M33.5M-2.96M12.9M12.9M2.63M-3.28M